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Chasing Unfolding Intermediates of IG Light Chains with Residual
Structures that Could Fit in an Amyloid Core
Gilberto Valdes-Garcia, Cesar Millan-Pacheco, Nina Pastor.
Facultad de Ciencias, Universidad Autonoma del Estado de Morelos,
Cuernavaca, Mexico.
Immunoglobulin light chains (LCs) deposit as insoluble aggregates causing a
disease called light chain amyloidosis (AL) [1]. Among the LC families, lambda
6a is very frequent inALpatients. Its germline protein (6aJL2) and pointmutants
(R24G, P7S and D52A) are good models to study fibrilllogenesis, because these
mutations have drastic effects in native state stability and in fibril formation
[2,3]. As yet, the conformational changes resulting in LC intermediates able to
form fibrils have not been characterized at the atomic level. At the very least,
these changes should involve eliminating the anti-aggregation motifs [4] and
rotating the b sheets so the strands become parallel [5]. From high temperature
molecular dynamic simulations of these proteins, we identified unfolding inter-
mediates filling the above criteria. The chosen structures retain native conforma-
tion, while the sides of the beta sandwich remain denatured. We quenched them
at 298 K and performed molecular dynamics simulations (10 replicates x 10 ns
each). Interestingly all the intermediates held their structured core within simu-
lation time, with an RMSD from the initial structure below 2.5 A˚. Based on the
hypothesis that early denaturation states of these proteins can lead to amyloid
aggregation, we propose that these intermediates could fit in the amyloid core,
and they could be stable enough to initiate the aggregation process.
[1] Dispenzieri A et al (2012) Blood Rev. 26: 137; [2] del Pozo-Yauner L et al
(2008) Proteins 72: 684; [3] Herna´ndez-Santoyo A et al (2010) J. Mol. Biol.
396: 280; [4] Richardson JS et al (2002) PNAS 99(5):2754; [5] Fa¨ndrich M
J. (2012) Mol. Biol. 421(4):427
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Backbone Dynamics Modulates the Amyloidogenic Propensity of
Transthyretin through Non-Native Intermediates
Aritra Bej, Jitendra K. Das, Shyam S. Mall, Sujoy Mukherjee.
Structural Biology and Bioinformatics Division, CSIR - Indian Institute of
Chemical Biology, Kolkata, India.
Transthyretin (TTR) is a ~55 kDa thyroxine transporter that forms amyloid fibrils
in a large number of protein aggregation diseases like senile systemic amyloid-
osis as well as neuropathies, cardiomyopathy, ocular, leptomeningeal, and other
forms of familial amyloidoses[1]. Previous studies have revealed that amyloid
formation is preceded by the disruption of the tertiary and quaternary structures
to form partially unfolded intermediates via conformational excursions out of
their ground state[2]. The transient nature and low population of these intermedi-
ates makes it difficult to characterize them. In recent work (Das et al., Angew.
Chem. Int. Ed., 2014, in press), we have quantified the backbone dynamics of
the wild-type and pathogenic TTR mutants (L55P, V30M, V122I) as well as a
protective variant (T119M) using NMR spectroscopy and MD simulations and
correlated conformational flexibility with their amyloidogenic propensity[3].
We have performed microsecond timescale atomistic MD simulations on many
TTR proteins to show that the pathogenic mutants exhibit significantly more
conformational perturbation than the wild-type. We further show that backbone
dynamics in pathogenic mutants energetically favour their transition to a more
stable non-native intermediates with respect to the wild-type. We are currently
working to understand the role of thermodynamics, specifically conformational
entropy based on the rotation of the polypeptide chain and trying to establish
its role among thepathogenicmutants and thewild-type.A successful completion
of this study will provide new structural insights into initial steps of TTR aggre-
gation that may help to develop therapeutics against TTR amyloidogenesis.
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Self-Replication of Transthyretin Amyloid Aggregates from Native
Tetramers in vitro
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University of South Florida, Tampa, FL, USA.The conversion of proteins from their native conformations into amyloid aggre-
gates with their beta -sheet enriched structures is associated with an increasing
number of pathological conditions including neurodegenerative disease and
systemic amyloidosis. Transthyretin (TTR) is a soluble human plasma protein
that is linked to both senile systemic amyloidosis (SSA) and familial amyloid
polyneuropathy (FAP) in humans. In vitro experiments have indicated that TTR
amyloid aggregation requires the dissociation of the native TTR tetramer into a
non-native monomer state. However, typical in-vitro experiments require the
use of non-physiological, acidic solution conditions. This raises the question
whether the mechanisms observed for TTR amyloid formation under harsh
in-vitro conditions match those active in vivo.
We have previously reported that lysozyme oligomers and curvilinear fibrils
were capable of prion-like self-replication from native monomers near physio-
logical solution conditions. We therefore investigated whether TTR amyloid
oligomers and their curvilinear fibrils were capable of similar self-replication
from their native tetrameric counterparts in vitro. We induced the formation
of TTR oligomers and curvilinear fibrils during transient thermal denaturation
in physiological saline. The morphologies and tinctorial characteristics of the
resulting aggregates match those for TTR oligomers and curvilinear fibrils
obtained by in vitro growth from acidic solutions. After mechanical separation
of these aggregates, they were seeded into solutions of native TTR tetramers at
physiological conditions (pH, temperature, ionic strength). Light scattering and
thioflavin T responses indicated that TTR oligomers and their curvilinear
fibrils, similar to our prior observations with lysozyme, induced conversion
of the native TTR tetramers into amyloids. Our observations suggest that
amyloid oligomers of different proteins have the capability for autocatalytic
self-replication from their native counterparts, thereby resembling the behavior
of prion proteins.
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SAS Profile Correlations Reveal the Hierarchical Nature of SAS Data and
Suggest New Scoring Strategies
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In structural biology, Small-Angle Scattering experiments (SAS) are unique,
because although they provide low resolution data, they can be performed in
closer-to-native conditions than those arising in X-Ray crystallography. A num-
ber of questions on SAS, however, remain unsolved, particularly in the light of
modelling ensembles of conformers in solution. In this letter, we study the
ensemble average and covariance of SAS profiles analytically. Using this
ensemble covariance, we demonstrate the hierarchical nature of SAS profiles.
Furthermore, we show that the information content is not uniform and reaches
its maximum in the intermediate q range. By taking into account correlated mo-
tions, we draw conclusions of profound importance to current scoring functions.
We give directions for new scoring strategies, which will be valuable for very
flexible systems, such as intrinsically disordered proteins.225-Pos Board B5
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Beta-sheet protein fibrils have been associated with many important patho-
logical conditions such as Alzheimer’s disease and type II diabetes. These
fibrils are also important in the emerging field of peptide drug delivery
since fibrillation is one of the critical degradation pathways for this class
of drug molecules. Moreover, these structures have bionanotechnological
applications such as formation of bio-nano-tubular scaffolds. Rational design
of anti-fibrillation drugs, stable formulation of peptide drug molecules and
development of bionanotechnological fibril devices all depend on under-
standing the structure of these fibrils. Although structures for some of such
fibrils are experimentally determined, there are many others for which no
structure is available. Hence, a computational method to model the structure
of beta-sheet rich fibrils will be very valuable. We have devised such a
computational method by combining homology modelling and MD simula-
tion. The process starts with homology modelling of the beta-sheet building
blocks using an optimized alignment and modelling scheme. Using those
building blocks higher structures of the fibril are constructed. Finally, MD
simulations are used to refine the fibril model and validate its energetic sta-
bility. We demonstrate the validity of our method by reproducing the exper-
imentally determined structure of a number of beta-sheet fibrils. We also
present the structure of glucagon beta-fibril for which no experimental struc-
ture is available. Understanding the structure of glucagon fibril can help
inhibiting its fibrillation which is a major obstacle facing glucagon drug
delivery.
